TFX · XBRL financial data

Teleflex financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (TFX's year ends in late December)

In millions of dollarsOct 1, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 29, 2024Dec 31, 2024Mar 30, 2025Jun 29, 2025Sep 28, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue from contracts with customers746774*738750764442701781913569548570
Cost of goods and services sold330342*322333334355*311350461(250)*241239
Gross profit416—416416430269389431452307307332
Research and development3836*37413945*36395713*4445
Selling, general and administrative213261*243251247255*2232152821*226214
Operating income (loss)16582*(5)11714952126155(409)142073
Interest income73*2222*2221*21
Interest expense2326*23212119*19223228*2628
Income tax expense (benefit)1229*(42)172010*1413(30)(31)*13
Net income (loss)13731*1580111(137)95123(409)(714)(8)100
Earnings per share, basic USD per share2.920.66*0.321.702.38(2.95)2.082.77(9.24)(16.15)(0.18)2.29
Earnings per share, diluted USD per share2.900.66*0.321.692.36(2.93)2.072.77(9.24)(16.15)(0.18)2.28
Weighted average shares, basic millions of shares4747*47474746*46444444*4444
Weighted average shares, diluted millions of shares4747*47474747*46444444*4444

Balance sheet

CSV

Fiscal quarters (TFX's year ends in late December)

In millions of dollarsOct 1, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 29, 2024Dec 31, 2024Mar 30, 2025Jun 29, 2025Sep 28, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents881223237239243290284254354379309300
Accounts receivable425443449449470459465514593346366365
Inventory625626628637640600644694802404381352
Prepaid and other current assets13910711295117118142199155151150148
Total current assets2,0971,4071,4341,4381,4991,4711,5391,7241,9861,9381,8601,876
Property and equipment, net464480486492512503519549701498477476
Right-of-use asset12412411311211310910899107928577
Goodwill2,5282,9142,8982,8932,9192,6322,6522,6942,5382,3052,2972,292
Total assets7,4947,5337,4787,4427,4867,0987,1637,3757,8726,9476,7836,787
Accounts payable131132116113119141143158166130144143
Accrued liabilities133147137153158143151157147117118134
Current portion of long-term debt8888———100100100100100—88
Total current liabilities585607571557619649676716773762728720
Long-term debt1,9501,7281,6681,6241,6621,5561,8071,8022,5722,5412,5142,721
Lease liability, non-current1121111041031039998949884163175
Total liabilities3,1803,0922,9752,8833,0052,8203,0683,1324,0503,8223,6993,882
Retained earnings—4,110———4,116———3,150——
Total stockholders' equity4,3144,4414,5034,5594,4824,2784,0954,2433,8223,1253,0842,905
Total liabilities and equity7,4947,5337,4787,4427,4867,0987,1637,3757,8726,9476,7836,787
Common shares outstanding (cover page) millions of shares474747474646444444444442

Cash flows

CSV

Fiscal quarters (TFX's year ends in late December)

In millions of dollarsOct 1, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 29, 2024Dec 31, 2024Mar 30, 2025Jun 29, 2025Sep 28, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)13731*1580111(137)95123(409)(714)(8)100
Stock-based compensation8*9*79*8*8*87*8*3*75*
Purchases of property and equipment24*28*3835*21*32*3035*30*1*1914*
Net cash from investing activities(28)*—(25)(30)*(21)*—(29)(30)*(768)*———
Share repurchases—0*00*200*0*3000*0*0*0250*
Dividends paid16*16*1616*16*16*1515*15*15*1515*
Proceeds from long-term debt—0*00*130*0*3000*840*0*02,350*
Repayments of long-term debt167*223*5741*90*103*496*66*31*252,150*
Net cash from financing activities462*(238)*(71)(57)*(175)*(119)*(60)(24)*756*(62)*(45)(82)*
Net change in cash631*(659)*151*39*50*(10)(34)*97*73*(85)(5)*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingRunwayQuarter
Teleflex300570not reported42.4M— 10-QJun 30, 2026
Haemonetics2233395245.5M— 10-QJun 27, 2026
LivaNova51739167*55.1M— 10-QJun 30, 2026
Envista Holdings1,126731119*160.6M— 10-QJul 3, 2026
Enovis1358375*57.7M— 10-QJul 3, 2026
Ufp Technologies917416*7.7M— 10-QJun 30, 2026
Lemaitre Vascular27not reported16*22.9M— 10-QJun 30, 2026
Dentsply Sirona23989899*199.4M— 10-QJun 30, 2026
PROCEPT BioRobotics22894(19)*57.3M11.8 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.